Home Cart Sign in  
Chemical Structure| 74258-86-9 Chemical Structure| 74258-86-9

Structure of Alacepril
CAS No.: 74258-86-9

Chemical Structure| 74258-86-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alacepril is a long-acting, sulfhydryl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.

Synonyms: DU-1219; Cetapril; Alaceprilum

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alacepril

CAS No. :74258-86-9
Formula : C20H26N2O5S
M.W : 406.50
SMILES Code : O=C(O)[C@@H](NC([C@H]1N(C([C@H](C)CSC(C)=O)=O)CCC1)=O)CC2=CC=CC=C2
Synonyms :
DU-1219; Cetapril; Alaceprilum
MDL No. :MFCD00869538
InChI Key :FHHHOYXPRDYHEZ-COXVUDFISA-N
Pubchem ID :71992

Safety of Alacepril

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.46mL

0.49mL

0.25mL

12.30mL

2.46mL

1.23mL

24.60mL

4.92mL

2.46mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

[1]Sakatani A, Miyagawa Y, et al. Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs. J Vet Cardiol. 2016 Sep;18(3):248-54.

[2]Nonoguchi H, Kiyama S, et al. Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure. Hypertens Res. 2008 Jan;31(1):29-36.

[3]Hori Y, Nakamura K, Kanno N, Hitomi M, Yamashita Y, Hosaka S, Isayama N, Mimura T. Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease. J Vet Med Sci. 2018 Aug 10;80(8):1212-1218

[4]Teramoto S, Suzuki M, Matsuse T, Ishii T, Fukuchi Y, Ouchi Y. Effects of angiotensin-converting enzyme inhibitors on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary disease. Jpn J Pharmacol. 2000 May;83(1):56-62

[5]Saitoh M, Miyakoda H, Kitamura H, Kinugawa T, Kotake H, Mashiba H. Effects of an angiotensin-converting enzyme inhibitor, alacepril, on cardiovascular and sympathetic nervous responses to mental stress in patients with essential hypertension. Intern Med. 1993 Sep;32(9):691-4

[6]Kinugawa T, Kitamura H, Ogino K, Noguchi N, Matsumoto T, Hisatome I, Miyakoda H, Kotake H, Mashiba H. Effect of alacepril on blood pressure and neurohumoral factors at rest and during dynamic exercise in patients with essential hypertension. Br J Clin Pharmacol. 1992 Oct;34(4):366-9

[7]Miyazaki M, Takai S. Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res. 1999 Mar;22(1):49-54

 

Historical Records

Categories